Lifecare ASA will release its second quarter 2024 results on Tuesday 27 august 2024 at 07:00 a.m. CEST.
The same day at 12:00 CEST, CEO Joacim Holter will present the results live at Carnegie AS, Fjordalleen 16, Aker Brygge in Oslo.
After the presentation, Lifecare invites to 1:1 session with the CEO and the CFO.
About us
Lifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s main focus is to bring the next generation of Continuous Glucose Monitoring (“CGM“) systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors (“NTR“) on the sensor body for read-out of pressure variations. Lifecare’s sensor technology is referred to as “Sencell” and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42
